$CYCA Cytta Corp. - America's Drone Reckoning: National

New Post Public Reply Private Reply Replies (0) Message Board
louied91
140
$CYCA Cytta Corp. - America's Drone Reckoning: National Security, Tariffs, and the Urgent Shift to Secure U.S.-Based Solutions

https://www.accessnewswire.com/newsroom/en/co...an-1040272

Recent moves by the U.S. government signal a major shift in how drone technologies are regulated and procured.

LAS VEGAS, NEVADA / ACCESS Newswire / June 17, 2025 / Cytta Corp.(OTCQB:CYCA), a publicly traded leader in national safety and communications technology, is proud to announce the recent Article in Officer.com magazine describing how our CyttaCOMMS technology is directly contributing to helping solve America's Drone problems at the National Security level.

America's Drone Reckoning Is Here. Chinese-made drones are silently collecting data - and the stakes just got higher. With new tariffs and rising national security concerns, the U.S. must act fast. This article breaks down why law enforcement and public safety agencies need to transition to secure, American-made drone technology-before it's too late.

https://www.officer.com/command-hq/technology...-solutions

Quoted from Officer.com Magazine

"As tensions between the United States and China continue to mount, the drone industry has found itself squarely in the crosshairs of a growing national security debate. With the majority of U.S. police departments still relying on Chinese-made drones-particularly DJI models-the vulnerabilities of foreign-controlled unmanned systems have become impossible to ignore.

Recent moves by the U.S. government signal a major shift in how drone technologies are regulated and procured. The Trump administration's announcement of sweeping new tariffs-including a cumulative 170% tariff on Chinese drones-is part of a broader push to bring critical technology back under American control. This builds on valid concerns that Chinese drones may be transmitting sensitive surveillance data back to foreign servers, compromising U.S. law enforcement and critical infrastructure operations.

Simultaneously, China has responded by imposing retaliatory sanctions on U.S. drone manufacturers and restricting exports of rare earth materials vital to aerospace and technology production. This tit-for-tat escalation underscores how drones have become a frontline issue not just in trade, but in the geopolitical race for tech dominance.

At the same time, Chinese drone developers are aggressively pursuing U.S. markets despite high tariffs, according to reports from the South China Morning Post. Their low-altitude aircraft are being positioned as high-value, cost-efficient alternatives, even as questions swirl about security risks and backdoor access.

This leaves U.S. agencies, especially law enforcement, in a difficult bind. Many are now under pressure to halt the use of DJI drones, but they lack the budget and infrastructure to replace entire fleets overnight-making immediate transitions both logistically and financially unfeasible. While the federal government is pushing for a transition to American-made alternatives, the U.S. drone manufacturing sector is still ramping up production capacity-and that's not a quick fix.

One of the biggest bottlenecks lies in sourcing the rare earth materials needed for drone electronics and power systems-many of which still come from China. Until domestic supply chains are fully built out, production timelines will be slow, and costs will remain high, placing added strain on already-stretched public safety budgets. For smaller law enforcement agencies and rural departments, upgrading to new American-made fleets may be financially out of reach.

That's where transitional solutions become crucial.

Given the widespread use of Chinese-manufactured drones across U.S. agencies-and the prohibitive cost of replacing entire fleets-the only immediate and scalable solution is to upgrade existing systems to prevent foreign data transmissions. Rather than removing DJI and similar drones from service, the more viable path is to retrofit them with secure, American-made communication layers that ensure mission-critical data remains within U.S. control. This urgent need has opened the door to a rapidly emerging technology market: one focused not on hardware replacement, but on data sovereignty through software and systems integration. Until the domestic drone ecosystem-like the DoD's Blue UAS program-can fully meet national demand, interim solutions like secure retrofit platforms will play a pivotal role in bridging the gap between policy and operational reality.

One small public company addressing this issue head-on is Cytta Corp.(OTCQB:CYCA), whose CyttaCOMMS platform is being expanded to block foreign data transmission from Chinese-manufactured drones. CyttaCOMMS, originally designed to deliver secure, real-time video and data communications for first responders, has already been accepted by law enforcement agencies across the country. The platform is now being enhanced to prevent Chinese drone systems from transmitting operational data back to foreign servers. This update empowers departments to continue using their existing drone fleets without compromising national security-offering a crucial, cost-effective alternative to full hardware replacement.

Rather than forcing agencies to abandon their DJI fleets, Cytta Corp. offers a secure bridge-allowing continued operations while ensuring that all mission-critical video and communication data remains encrypted, protected, and stored domestically. As American drone manufacturers race to scale, technological innovations provide a timely and practical way to ensure operational continuity and immediate compliance with evolving federal mandates.

The message is clear: America's drone future must be secure, sovereign, and strategically independent. Whether through policy, innovation, or transitional technologies, the industry is entering a pivotal era-where national security and technological agility must go hand in hand."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Kinetic Seas Incorporated Secures First Customer Success

Updated Category News Views 56

Kinetic Seas Incorporated Secures First Customer and Financial Growth Kinetic Seas Incorporated (OTC: ECGR) is excited to announce the signing of its first customer, along with impressive revenue results for the second quarter. This milestone marks a significant step forward as the company pursues its goals in the artificial intelligence sector. Second Quarter Revenue...

Continue Reading
Webinar Guide for Veterans to Maximize Benefits Offered by CCK Law

Updated Category News Views 134

Helping Veterans Discover VA Benefits with a Free Webinar Chisholm Chisholm & Kilpatrick LTD (CCK Law), a preeminent veterans disability law firm, is excited to introduce a free, on-demand webinar aimed at assisting veterans in uncovering valuable VA benefits that many may be unaware of. Insights from the Experts The webinar, dubbed "Biggest Benefits Veterans Overlook,"...

Continue Reading
Tech Market Shifts: Navigating Opportunities and Challenges Ahead

Updated Category News Views 161

Understanding Recent Market Dynamics In recent weeks, global markets have been experiencing heightened volatility, particularly in the technology sector. With various significant events unfolding—including new political leadership in Japan and shifts in economic data—investors are carefully analyzing these developments to navigate potential risks and opportunities....

Continue Reading
Michael Beland Joins Advance Auto Parts as Chief Accounting Officer

Updated Category News Views 720

Welcome Michael Beland to Advance Auto Parts Advance Auto Parts, Inc. (NYSE: AAP), known for its significant role in the automotive aftermarket, recently made an important announcement regarding its executive leadership. The company has appointed Michael Beland as the new senior vice president, controller, and chief accounting officer, marking a pivotal addition to their...

Continue Reading
Recall Movement Against Governor Newsom Gains Momentum

Updated Category News Views 276

Recall Movement Gains Traction in California In an unprecedented move, SavingCalifornia.vote has taken a significant step to initiate a recall against Governor Gavin Newsom. This initiative marks a pivotal moment in California's political landscape. The organization is gathering support and will soon submit the official notice of intent to recall, alongside the necessary...

Continue Reading